KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Notes Payables (2017 - 2018)

Astrana Health's Notes Payables history spans 5 years, with the latest figure at $40257.0 for Q4 2018.

  • For Q4 2018, Notes Payables fell 92.11% year-over-year to $40257.0; the TTM value through Dec 2018 reached $40257.0, down 92.11%, while the annual FY2018 figure was $40257.0, 92.11% down from the prior year.
  • Notes Payables for Q4 2018 was $40257.0 at Astrana Health, down from $278017.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $4.9 million in Q3 2017 and bottomed at $40257.0 in Q4 2018.
  • The 4-year median for Notes Payables is $1.1 million (2015), against an average of $2.0 million.
  • The largest annual shift saw Notes Payables rose 29.45% in 2017 before it tumbled 94.31% in 2018.
  • A 4-year view of Notes Payables shows it stood at $1.1 million in 2015, then tumbled by 63.96% to $394267.0 in 2016, then increased by 29.45% to $510391.0 in 2017, then plummeted by 92.11% to $40257.0 in 2018.
  • Per Business Quant, the three most recent readings for ASTH's Notes Payables are $40257.0 (Q4 2018), $278017.0 (Q2 2018), and $394783.0 (Q1 2018).